{"id":31266,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/","title":{"rendered":"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1471 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Bruselas 2018<\/h2>\n<p>La evidencia en la vida real es la mejor manera de entender c\u00f3mo identificar a los pacientes que responden a los diferentes f\u00e1rmacos y c\u00f3mo obtener beneficios de esta investigaci\u00f3n. Obtenga m\u00e1s informaci\u00f3n sobre la eficacia y el \u00e9xito del tratamiento, as\u00ed como sobre la evidencia cl\u00ednica de los biol\u00f3gicos en este episodio. <\/p>\n<h3>Panelistas<\/h3>\n<p>Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1472 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Reproductor de v\u00eddeo de YouTube\" src=\"https:\/\/www.youtube.com\/embed\/0xkyGfRWcEc?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Bruselas 2018 La evidencia en la vida real es la mejor manera de entender c\u00f3mo identificar a los pacientes que responden a los diferentes f\u00e1rmacos y c\u00f3mo obtener beneficios de esta investigaci\u00f3n. Obtenga m\u00e1s informaci\u00f3n sobre la eficacia y el \u00e9xito del tratamiento, as\u00ed como sobre la evidencia cl\u00ednica de los biol\u00f3gicos en este episodio. Panelistas Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.<\/p>\n","protected":false},"author":1,"featured_media":31284,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[202],"tags":[177,178,179,203,205,206,209,176],"class_list":["post-31266","news","type-news","status-publish","has-post-thumbnail","hentry","category-debates-futuros-de-rinologia","tag-asma","tag-rscpn","tag-biologicos","tag-rinologia","tag-debates","tag-debates-futuros-de-rinologia","tag-rinosinusitis-cronica-rsc","tag-profesionales-sanitarios"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Bruselas 2018 La evidencia en la vida real es la mejor manera de entender c\u00f3mo identificar a los pacientes que responden a los diferentes f\u00e1rmacos y c\u00f3mo obtener beneficios de esta investigaci\u00f3n. Obtenga m\u00e1s informaci\u00f3n sobre la eficacia y el \u00e9xito del tratamiento, as\u00ed como sobre la evidencia cl\u00ednica de los biol\u00f3gicos en este episodio. Panelistas Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/\",\"name\":\"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_17.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_17.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_17.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/elige-tu-camino\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/","og_locale":"es_ES","og_type":"article","og_title":"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma","og_description":"Rhinology Future Debates Bruselas 2018 La evidencia en la vida real es la mejor manera de entender c\u00f3mo identificar a los pacientes que responden a los diferentes f\u00e1rmacos y c\u00f3mo obtener beneficios de esta investigaci\u00f3n. Obtenga m\u00e1s informaci\u00f3n sobre la eficacia y el \u00e9xito del tratamiento, as\u00ed como sobre la evidencia cl\u00ednica de los biol\u00f3gicos en este episodio. Panelistas Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.","og_url":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"width":1280,"height":720,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/","url":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/","name":"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/es\/news\/evidencia-clinica-de-los-biologicos-en-la-rsccpn-y-el-asma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.euforea.org\/es\/elige-tu-camino\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/es\/news\/"},{"@type":"ListItem","position":3,"name":"Evidencia cl\u00ednica de los biol\u00f3gicos en la RSCcPN y el asma"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/es\/#website","url":"https:\/\/www.euforea.org\/es\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/es\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/31266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/comments?post=31266"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/31266\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media\/31284"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media?parent=31266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/categories?post=31266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/tags?post=31266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}